More diversity needed in dementia studies to enhance targeted therapies

A lack of diversity in genomic studies for dementia could limit the effectiveness of targeted therapies across underrepresented populations, finds research by UCL experts.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup